TY - JOUR
T1 - A rare missense variant of CASP7 is associated with familial late-onset Alzheimer's disease
AU - Alzheimer's Disease Sequencing Project
AU - Zhang, Xiaoling
AU - Zhu, Congcong
AU - Beecham, Gary
AU - Vardarajan, Badri N.
AU - Ma, Yiyi
AU - Lancour, Daniel
AU - Farrell, John J.
AU - Chung, Jaeyoon
AU - Bellair, Michelle
AU - Dinh, Huyen
AU - Doddapeneni, Harsha
AU - Dugan-Perez, Shannon
AU - English, Adam
AU - Gibbs, Richard A.
AU - Han, Yi
AU - Hu, Jianhong
AU - Jayaseelan, Joy
AU - Kalra, Divya
AU - Khan, Ziad
AU - Korchina, Viktoriya
AU - Lee, Sandra
AU - Liu, Yue
AU - Liu, Xiuping
AU - Muzny, Donna
AU - Nasser, Waleed
AU - Salerno, William
AU - Santibanez, Jireh
AU - Skinner, Evette
AU - White, Simon
AU - Worley, Kim
AU - Zhu, Yiming
AU - Beiser, Alexa
AU - Chen, Yuning
AU - Cupples, L. Adrienne
AU - DeStefano, Anita
AU - Dupuis, Josee
AU - Farrell, John
AU - Farrer, Lindsay
AU - Lin, Honghuang
AU - Liu, Ching Ti
AU - Lunetta, Kathy
AU - Patel, Devanshi
AU - Sarnowski, Chloe
AU - Satizabal, Claudia
AU - Seshadri, Sudha
AU - Sun, Fangui Jenny
AU - Choi, Seung Hoan
AU - Goate, Alison
AU - Marcora, Edoardo
AU - Renton, Alan
N1 - Funding Information:
This work was supported in part by NIA grants R01AG048927, P30-AG13846, and RF1AG057519. The Alzheimer's Disease Sequencing Project (ADSP) is comprised of two Alzheimer's disease genetics consortia and three National Human Genome Research Institute (NHGRI) funded Large Scale Sequencing and Analysis Centers (LSAC). The two AD genetics consortia are the Alzheimer's Disease Genetics Consortium (ADGC) funded by the National Institute on Aging (NIA) grant U01-AG032984 and the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) funded by NIA (R01 AG033193), the National Heart, Lung, and Blood Institute (NHLBI), and other National Institute of Health (NIH) institutes and foreign governmental and nongovernmental organizations. The discovery phase analysis of sequence data is supported through UF1-AG047133 (Drs. J.J.F, J.L.H., R.M., M.A.P.-V., and G.D.S.); U01-AG049505 to Dr. Sudha Seshadri; U01-AG049506 to Dr. Eric Boerwinkle; U01-AG049507 to Dr. Ellen Wijsman; and U01-AG049508 to Dr. Alison Goate) and the Discovery Extension Phase analysis is supported through U01-AG052411 to Dr. Goate, U01-AG052410 to Dr. Pericak-Vance, and U01-AG052409 to Drs. Seshadri and Myriam Fornage. Data generation and harmonization in the follow-up phases are supported by U54-AG052427 to Drs. Schellenberg and Li-San Wang. The authors thank the investigators who assembled and characterized participants of cohorts included in this study:
Funding Information:
This work was supported in part by NIA grants R01AG048927 , P30-AG13846 , and RF1AG057519 . The Alzheimer's Disease Sequencing Project (ADSP) is comprised of two Alzheimer's disease genetics consortia and three National Human Genome Research Institute (NHGRI) funded Large Scale Sequencing and Analysis Centers (LSAC). The two AD genetics consortia are the Alzheimer's Disease Genetics Consortium (ADGC) funded by the National Institute on Aging ( NIA) grant U01-AG032984 and the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) funded by NIA ( R01 AG033193 ), the National Heart, Lung, and Blood Institute (NHLBI), and other National Institute of Health (NIH) institutes and foreign governmental and nongovernmental organizations. The discovery phase analysis of sequence data is supported through UF1-AG047133 (Drs. J.J.F, J.L.H., R.M., M.A.P.-V., and G.D.S.); U01-AG049505 to Dr. Sudha Seshadri; U01-AG049506 to Dr. Eric Boerwinkle; U01-AG049507 to Dr. Ellen Wijsman; and U01-AG049508 to Dr. Alison Goate) and the Discovery Extension Phase analysis is supported through U01-AG052411 to Dr. Goate, U01-AG052410 to Dr. Pericak-Vance, and U01-AG052409 to Drs. Seshadri and Myriam Fornage. Data generation and harmonization in the follow-up phases are supported by U54-AG052427 to Drs. Schellenberg and Li-San Wang. The authors thank the investigators who assembled and characterized participants of cohorts included in this study:
Publisher Copyright:
© 2018 The Authors
PY - 2019/3
Y1 - 2019/3
N2 - Introduction: The genetic architecture of Alzheimer's disease (AD) is only partially understood. Methods: We conducted an association study for AD using whole sequence data from 507 genetically enriched AD cases (i.e., cases having close relatives affected by AD) and 4917 cognitively healthy controls of European ancestry (EA) and 172 enriched cases and 179 controls of Caribbean Hispanic ancestry. Confirmation of top findings from stage 1 was sought in two family-based genome-wide association study data sets and in a whole genome–sequencing data set comprising members from 42 EA and 115 Caribbean Hispanic families. Results: We identified associations in EAs with variants in 12 novel loci. The most robust finding is a rare CASP7 missense variant (rs116437863; P = 2.44 × 10−10) which improved when combined with results from stage 2 data sets (P = 1.92 × 10−10). Discussion: Our study demonstrated that an enriched case design can strengthen genetic signals, thus allowing detection of associations that would otherwise be missed in a traditional case-control study.
AB - Introduction: The genetic architecture of Alzheimer's disease (AD) is only partially understood. Methods: We conducted an association study for AD using whole sequence data from 507 genetically enriched AD cases (i.e., cases having close relatives affected by AD) and 4917 cognitively healthy controls of European ancestry (EA) and 172 enriched cases and 179 controls of Caribbean Hispanic ancestry. Confirmation of top findings from stage 1 was sought in two family-based genome-wide association study data sets and in a whole genome–sequencing data set comprising members from 42 EA and 115 Caribbean Hispanic families. Results: We identified associations in EAs with variants in 12 novel loci. The most robust finding is a rare CASP7 missense variant (rs116437863; P = 2.44 × 10−10) which improved when combined with results from stage 2 data sets (P = 1.92 × 10−10). Discussion: Our study demonstrated that an enriched case design can strengthen genetic signals, thus allowing detection of associations that would otherwise be missed in a traditional case-control study.
KW - Association study
KW - Enriched case-control
KW - Gene-based analyses
KW - Genome-wide association studies
KW - Whole exome sequencing
UR - http://www.scopus.com/inward/record.url?scp=85059426701&partnerID=8YFLogxK
U2 - 10.1016/j.jalz.2018.10.005
DO - 10.1016/j.jalz.2018.10.005
M3 - Article
C2 - 30503768
AN - SCOPUS:85059426701
SN - 1552-5260
VL - 15
SP - 441
EP - 452
JO - Alzheimer's and Dementia
JF - Alzheimer's and Dementia
IS - 3
ER -